Suppr超能文献

用于药理学评估的人前列腺组织的组织培养物。

Histocultures of human prostate tissues for pharmacologic evaluation.

作者信息

Wientjes M G, Pretlow T G, Badalament R A, Burgers J K, Au J L

机构信息

Division of Urology, College of Pharmacy, Ohio State University, Columbus.

出版信息

J Urol. 1995 Apr;153(4):1299-302.

PMID:7532726
Abstract

This study evaluated the growth of human prostate tumors in histoculture, an in vitro culture technique that maintains three-dimensional tissue structure and organization. Eighty-six percent of 50 tumor specimens from 50 patients were successfully cultured. The histocultures showed proliferation of epithelial tumor cells and stromal cells. Prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) were detectable by immunohistochemistry for at least 8 weeks. Synthesis of PSA was further confirmed by its presence in medium. The mean thymidine labeling index (LI) of the neoplastic cells was 62%. There was no correlation between thymidine LI and tumor grade. The explants maintained their characteristics for at least 8 weeks as indicated by unchanged thymidine LI, PSA and PAP immunohistochemistry after 2 and 8 weeks in culture. A 24 to 48 hour delay in processing the tissues for culture did not reduce the thymidine LI. The thymidine LI and PSA and PAP staining in tumors cultured in a Minimal Essential Medium (MEM)-based or a PFMR-4-based culture medium were similar, suggesting an insignificant effect of the medium on cell proliferation. Migration of neoplastic cells from the tissue fragments into the collagen gel matrix was noted in 1 of 10 samples cultured in MEM-based medium versus 8 of 10 samples cultured in PFMR-4 medium (p < 0.01). Exposure of 13 patient tumors to suramin, doxorubicin and 5-fluorouracil at clinically relevant concentrations and duration showed tumor sensitivity in 23%, 31% and 15% of the specimens. These values approximate the historical clinical response rates. These data suggest that the histoculture system holds promise for short-term culture of human patient prostate tumor specimens for biologic and pharmacologic studies.

摘要

本研究评估了人前列腺肿瘤在组织培养中的生长情况,组织培养是一种能维持三维组织结构和组织形态的体外培养技术。来自50名患者的50个肿瘤标本中有86%成功培养。组织培养显示上皮肿瘤细胞和基质细胞增殖。通过免疫组织化学检测,前列腺特异性抗原(PSA)和前列腺酸性磷酸酶(PAP)至少在8周内可检测到。培养基中PSA的存在进一步证实了其合成。肿瘤细胞的平均胸腺嘧啶核苷标记指数(LI)为62%。胸腺嘧啶核苷LI与肿瘤分级之间无相关性。培养2周和8周后,外植体的胸腺嘧啶核苷LI、PSA和PAP免疫组织化学未发生变化,表明其特性至少维持了8周。组织培养处理延迟24至48小时并未降低胸腺嘧啶核苷LI。在基于最低限度基本培养基(MEM)或基于PFMR-4的培养基中培养的肿瘤,其胸腺嘧啶核苷LI以及PSA和PAP染色相似,表明培养基对细胞增殖的影响不显著。在基于MEM的培养基中培养的10个样本中有1个、而在基于PFMR-4的培养基中培养的10个样本中有8个观察到肿瘤细胞从组织碎片迁移到胶原凝胶基质中(p<0.01)。13例患者的肿瘤在临床相关浓度和持续时间下暴露于苏拉明、阿霉素和5-氟尿嘧啶,结果显示分别有23%、31%和15%的标本出现肿瘤敏感性。这些数值接近历史临床反应率。这些数据表明,组织培养系统有望用于对人类患者前列腺肿瘤标本进行短期培养,以开展生物学和药理学研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验